Ioanna Krikki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ioanna Krikki has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adelheid Hainzl
Faculty of Medicine, University of Ulm, 89081 Ulm, Germany
1 shared publication - Carsten M. Kroeger
Department of Dermatology and Allergic Diseases, University of Ulm, 89081 Ulm, Germany
1 shared publication - Christina Wilms
Department of Dermatology and Allergic Diseases, University of Ulm, 89081 Ulm, Germany
1 shared publication - Evgenia Makrantonaki
Universitätsklinikum Ulm
1 shared publication - Marius Alupei
Department of Dermatology and Allergic Diseases, Ulm University Medical Center , 89081 Ulm , Germany
1 shared publication - Martina Gatzka
Department of Dermatology and Allergic Diseases, University of Ulm, 89081 Ulm, Germany
1 shared publication
Latest Publications
- Open Access
- 28 February 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (3) , 687
2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs
Development and homeostasis of the epidermis are governed by a complex network of sequence-specific transcription factors and epigenetic modifiers cooperatively regulating the subtle balance of progenitor cell self-renewal and terminal differentiation. To investigate the role of histone H2A deubiquitinase 2A-DUB/Mysm1 in the skin, we systematically analyzed expression, developmental functions, and potential interactions of this epigenetic regulator using Mysm1-deficient mice and skin-derived epidermal cells. Morphologically, skin of newborn and young adult Mysm1-deficient mice was atrophic with reduced thickness and cellularity of epidermis, dermis, and subcutis, in context with altered barrier function. Skin atrophy correlated with reduced proliferation rates in Mysm1−/− epidermis and hair follicles, and increased apoptosis compared with wild-type controls, along with increases in DNA-damage marker γH2AX. In accordance with diminished α6-Integrinhigh+CD34+ epidermal stem cells, reduced colony formation of Mysm1−/− epidermal progenitors was detectable in vitro. On the molecular level, we identified p53 as potential mediator of the defective Mysm1-deficient epidermal compartment, resulting in increased pro-apoptotic and anti-proliferative gene expression. In Mysm1−/−p53−/− double-deficient mice, significant recovery of skin atrophy was observed. Functional properties of Mysm1−/− developing epidermis were assessed by quantifying the transepidermal water loss. In summary, this investigation uncovers a role for 2A-DUB/Mysm1 in suppression of p53-mediated inhibitory programs during epidermal development.
- 28 February 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (3) , 687
Open Access2A-DUB/Mysm1 Regulates Epidermal Development in Part by Suppressing p53-Mediated Programs
Development and homeostasis of the epidermis are governed by a complex network of sequence-specific transcription factors and epigenetic modifiers cooperatively regulating the subtle balance of progenitor cell self-renewal and terminal differentiation. To investigate the role of histone H2A deubiquitinase 2A-DUB/Mysm1 in the skin, we systematically analyzed expression, developmental functions, and potential interactions of this epigenetic regulator using Mysm1-deficient mice and skin-derived epidermal cells. Morphologically, skin of newborn and young adult Mysm1-deficient mice was atrophic with reduced thickness and cellularity of epidermis, dermis, and subcutis, in context with altered barrier function. Skin atrophy correlated with reduced proliferation rates in Mysm1−/− epidermis and hair follicles, and increased apoptosis compared with wild-type controls, along with increases in DNA-damage marker γH2AX. In accordance with diminished α6-Integrinhigh+CD34+ epidermal stem cells, reduced colony formation of Mysm1−/− epidermal progenitors was detectable in vitro. On the molecular level, we identified p53 as potential mediator of the defective Mysm1-deficient epidermal compartment, resulting in increased pro-apoptotic and anti-proliferative gene expression. In Mysm1−/−p53−/− double-deficient mice, significant recovery of skin atrophy was observed. Functional properties of Mysm1−/− developing epidermis were assessed by quantifying the transepidermal water loss. In summary, this investigation uncovers a role for 2A-DUB/Mysm1 in suppression of p53-mediated inhibitory programs during epidermal development.